Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

Retrotope RT0001 Clinical Trial Update

Update on the RT0001 study: In August 2015, Retrotope launched a Phase 1 study of RT0001 in individuals with FA, ages 18-50 years. This study is enrolling two dose cohorts. The first dose cohort has been fully screened enrolled in the protocol. We anticipate beginning the second dose cohort of 9 individuals in February 2016. Thank you to everyone in the FA community who is participating in the study.

For more information about this trial and sites participating visit,


Event A.jpg


Archived in
  Scientific News



Tagged in
FARA Scientific News

Site Map     Privacy Policy     Service Terms     Log-in     Contact     Charity Navigator